GGrantIndex
Sort

39,280 grants matching leukemia

Genomics of myelodysplastic syndromes

$522,916
Timothy A Graubert · Washington University · R01 · FY2006 · HL

Dynamics of Tumor Stem Cells in Cancer Initiation, Therapy, and Resistance

$522,904
Franziska Michor · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA

Role of GM-CSF in Alveolar Macrophage Self-Renewal

$522,665
Paritha Arumugam · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · HL

Genetic Predictors of AML Treatment Response

$522,609
Richard Aplenc · Children'S Hosp Of Philadelphia · R01 · FY2013 · CA

Molecular Genetics of Dyskeratosis Congenita

$522,587
Alison Ann Bertuch · Baylor College Of Medicine · R01 · FY2016 · HL

DNMT3A in Development of Hematologic Malignancies

$522,576
Margaret Goodell · Baylor College Of Medicine · R01 · FY2022 · CA

DNMT3A in Development of Hematologic Malignancies

$522,576
Margaret Goodell · Baylor College Of Medicine · R01 · FY2023 · CA

Mitochondrial NAD+ in Acute Myeloid Leukemias

$522,539
Xiaolu Ang Cambronne · University Of Texas At Austin · R01 · FY2023 · CA

Mitochondrial NAD+ in Acute Myeloid Leukemias

$522,539
Xiaolu Ang Cambronne · University Of Texas At Austin · R01 · FY2025 · CA

REGULATION OF NEUROENDOCRINE SWITCHING EVENTS

$522,370
University Of California San Diego · R37 · FY2004 · DK

The Role of PHF6 in HSC self-renewal and myeloid expansion

$522,039
Vikram R. Paralkar · University Of Pennsylvania · R01 · FY2024 · HL

The impact of inflammation on HSPC composition and disease progression in chronic myelomonocytic leukemia

$522,013
Eric Padron · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA

THE APL PARADIGM FOR ABERRANT TRANSCRIPTION, CANCER AND

$521,922
Sloan-Kettering Institute For Cancer Res · U01 · FY2002 · CA

Pre-and Postgraduate Training in Molecular Hematology

$521,878
Stephen Tracy Oh · Washington University · T32 · FY2022 · HL

Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis

$521,786
Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA

Enhancing the Potency and Durability  of Immunotherapies

$521,774
Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2018 · CA

Mechanisms of Murine Turmor Eradication by Immunotherapy

$521,765
Philip D Greenberg · University Of Washington · R01 · FY2014 · CA

Mcl-1 in apoptosis and signal transduction: a structure/function approach

$521,604
Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · CA

Genome-wide CRISPR screening identifies critical regulators controlling ccRCC lung metastasis

$521,579
Qing Zhang · Ut Southwestern Medical Center · R01 · FY2025 · CA

BCR-ABL Kinase Assays for STI571 Sensitivity of Response

$521,577
University Of Chicago · R33 · FY2004 · CA

Investigations of menin function in Ewing sarcoma

$521,561
Elizabeth R Lawlor · Seattle Children'S Hospital · R01 · FY2021 · CA

Molecular Genetics

$521,506
Carlo M Croce · University Of California, San Diego · P01 · FY2013 · CA

Adapting flow cytometry methods for early detection of acute hematologic malignancies in Kenya including the improvement of sample flow processes and technical training of personnel

$521,488
Terry A Vik · Indiana University Indianapolis · R01 · FY2024 · CA

Collaborative Pathways that Lead to Leukemia

$521,480
Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Activation of Proto-Oncogenes by Chromosomal Translocation

$521,480
Peter Aplan · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA